Systemic interleukins levels in community-acquired pneumonia and their association with adverse outcomes

Abstract

Introduction: Community-acquired pneumonia (CAP) is still one of the major causes of morbidity and mortality worldwide. Pro-inflammatory and anti-inflammatory interleukins have been studied to elucidate the role that inflammation plays in its pathogenesis. The aim of this study is to investigate inflammation in CAP, by analyzing in dynamic, serum levels of six interleukins (IL) and their predictive value regarding adverse outcomes.

Keywords

• community-acquired pneumonia
• interleukins
• adverse outcomes